Diluted EPS came in at $-3.38, missed the $-0.57 consensus by $2.81.
Trailing eight quarters through Q4 2024
Common questions about Sionna Therapeutics, Inc. Common Stock's Q4 2024 earnings report.
Sionna Therapeutics, Inc. Common Stock (SION) reported Q4 2024 earnings on March 20, 2025 before market open.
Sionna Therapeutics, Inc. Common Stock reported diluted EPS of $-3.38 for Q4 2024.
EPS missed the consensus estimate of $-0.57 by $2.81.
You can read the 10-K periodic report (0002036042-25-000005) directly on SEC EDGAR. The filing index links above go to sec.gov.